MANE

Veradermics, Incorporated

Healthcare · Biotechnology

116.80$ -0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MANE
Line item	2023	2024	2025
Revenue	0.00	0.00	0.00
Research & Development	0.07	0.12	1.77
Selling, General & Administrative	0.01	0.02	0.29
Total Operating Expenses	0.09	0.13	2.06
Operating Income	-0.09	-0.13	-2.06
Interest Expense	0.00	0.00	0.00
Pre-Tax Income	-0.08	-0.13	-2.00
Net Income	-0.08	-0.13	-2.00
EBITDA	-0.08	-0.13	-2.00

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.